CAQ-Psychiatry study materials
CAQ-Psychiatry study resources

Bipolar I Disorder and Unplanned Pregnancy on Valproate

CAQ-Psychiatry · Put your knowledge to work in context.

All case studies

Bipolar I Disorder and Unplanned Pregnancy on Valproate

A 29-year-old woman with bipolar I disorder presents at 9 weeks' gestation after an unplanned pregnancy. She has been maintained on valproate 1,000 mg/day for 3 years, with two prior manic episodes requiring hospitalization, one after stopping lithium. She reports 5 days of decreased sleep, racing thoughts, and spending sprees; her partner says she is 'talking nonstop.' She is tearful about the pregnancy and says she 'cannot be a mother on these medicines.' She has no current suicidal ideation but has intrusive thoughts of ending the pregnancy. Her obstetrician advises stopping all psychotropics. She wants to know whether she can 'just stop everything.' BMI is 27, blood pressure 118/74, lithium level 0.6 mmol/L, creatinine 0.8. She has no fetal ultrasound yet and takes no folic acid.

1. How do you weigh the risks of untreated bipolar disorder against medication exposures in pregnancy?

Read the worked answer

The key judgment is that neither 'stop everything' nor 'continue valproate unchanged' is safe. Valproate exposure in the first trimester carries the highest teratogenic risk among common mood stabilizers, including neural tube defects and neurodevelopmental harm. Untreated bipolar I disorder in pregnancy carries high relapse risk, especially after abrupt discontinuation, with risks of mania, suicide, poor prenatal care, and postpartum psychosis. I would use shared decision-making, document the risk discussion, and involve perinatal psychiatry and high-risk obstetrics. Reasonable options include switching to an antipsychotic with more reproductive data (e.g., quetiapine) and/or lithium after counseling about the small absolute increase in Ebstein anomaly and the need for level II ultrasound and fetal echocardiography. I would start folic acid 5 mg daily, avoid valproate, and not stop medications abruptly. If she chooses to taper, I would do so slowly with close monitoring.

2. What acute treatment would you recommend for her current manic symptoms, and what monitoring is required?

Read the worked answer

She has 5 days of decreased sleep, racing thoughts, and spending sprees at 9 weeks' gestation-probable mania. I would treat aggressively because mania itself threatens the pregnancy. Quetiapine is a reasonable first choice given its use in bipolar mania and relatively favorable pregnancy data; olanzapine is an alternative but carries more metabolic risk. Lithium is also an option if she is reliable for monitoring, but it requires serum levels, renal and thyroid checks, and fetal monitoring. I would avoid valproate and carbamazepine. If she is severely agitated, not eating, or psychotic, ECT is a safe and effective option in pregnancy. Monitoring includes maternal vital signs, metabolic panel, lithium level if used, fetal growth, and obstetric co-management. I would also address sleep, hydration, and safety.

3. How do you address her ambivalence about the pregnancy and intrusive thoughts?

Read the worked answer

I would separate the psychiatric emergency from the reproductive decision. Her intrusive thoughts of ending the pregnancy are not necessarily delusional; they may reflect ambivalence, fear, and depression. I would assess suicide risk, psychosis, and coercion, and I would not pressure her either way. I would use motivational interviewing, explore what 'being a mother on these medicines' means, and correct misinformation. I would offer perinatal peer support and ethics consultation if needed. If she is in acute mania, decision-making capacity for complex reproductive decisions may be impaired, so I would stabilize first and revisit. I would document that the discussion was non-directive and that she understands options, including continuation, adoption, and termination within legal limits. Safety planning and rapid follow-up are essential.